Todd Brown, MD, PhD

CRS:

JHU

Role:

Investigators

Position:

Co-investigator

Email:

Tbrown27@jhmi.edu
  • Member, Bone Complications Working Group of the Inflammation TSG (Aug 2008 – Present)
  • Member, Immune Activation Focus Group of Inflammation TSG (Aug 2014-Present)
  • Protocol Co-Chair, ACTG 5260s, ACTG 5318 (LEACH)
  • Protocol Vice-Chair, ACTG 5280, ACTG 5303
  • Co-chair, ACTG 5361s
  • Co-investigator, ACTG 5257

Categories

Leadership Committees
CRS
Roles

Clinical Trials

P2001 (DAIDS ID 12026): Evaluating the Pharmacokinetics,...

TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...

Read More

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More

A5225: Phase I/II Dose-Finding Study of High-Dose...

A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...

Read More

ACTIV-2/A5401: Adaptive Platform Treatment for Outpatients...

Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...

Read More

A5273: Multicenter Study of Options for Second-Line...

The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...

Read More